Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions

Gram-positive bacteria

  • Clinical Therapeutics
    Use of Pristinamycin for Infections by Gram-Positive Bacteria: Clinical Experience at an Australian Hospital
    A. B. Reid, J. R. Daffy, P. Stanley, K. L. Buising
  • Susceptibility
    Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges
    Steven D. Brown, Maria M. Traczewski
  • Susceptibility
    CEM-101 Activity against Gram-Positive Organisms
    Leah N. Woosley, Mariana Castanheira, Ronald N. Jones
  • Susceptibility
    Peptide Fragments of a β-Defensin Derivative with Potent Bactericidal Activity
    Natalie L. Reynolds, Martin De Cecco, Karen Taylor, Chloe Stanton, Fiona Kilanowski, Jason Kalapothakis, Emily Seo, Dusan Uhrin, Dominic Campopiano, John Govan, Derek Macmillan, Perdita Barran, Julia R. Dorin
  • Experimental Therapeutics
    Synergistic Antimicrobial Activities of Folic Acid Antagonists and Nucleoside Analogs
    Johannes Zander, Silke Besier, Hanns Ackermann, Thomas A. Wichelhaus
  • Susceptibility
    In Vitro Activities of Three New Dihydrofolate Reductase Inhibitors against Clinical Isolates of Gram-Positive Bacteria
    Karen E. Bowker, Patrick Caspers, Bérengère Gaucher, Alasdair P. MacGowan
  • Susceptibility
    Comparative In Vitro Activity Profile of Oritavancin against Recent Gram-Positive Clinical Isolates
    Francis F. Arhin, Deborah C. Draghi, Chris M. Pillar, Thomas R. Parr, Gregory Moeck, Daniel F. Sahm
  • Mechanisms of Action: Physiological Effects
    Antibacterial Properties and Mode of Action of a Short Acyl-Lysyl Oligomer
    Fadia Zaknoon, Hadar Sarig, Shahar Rotem, Liran Livne, Andrey Ivankin, David Gidalevitz, Amram Mor
  • Susceptibility
    Activities of Dalbavancin against a Worldwide Collection of 81,673 Gram-Positive Bacterial Isolates
    Douglas J. Biedenbach, Jan M. Bell, Helio S. Sader, John D. Turnidge, Ronald N. Jones
  • Susceptibility
    In Vitro Antimicrobial Activity of a New Cephalosporin, Ceftaroline, and Determination of Quality Control Ranges for MIC Testing
    Steven D. Brown, Maria M. Traczewski

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
Back to top

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596